Human pathogenic viruses are retained in and released by Candida albicans biofilm in vitro

Virus Research

Volumn 179, Issue 1, 2014, Pages 153-160

  Mazaheritehrani, Elham ^a   Sala, Arianna ^a   Orsi, Carlotta Francesca ^a,b   Neglia, Rachele Giovanna ^a   Morace, Giulia ^b   Blasi, Elisabetta ^a   Cermelli, Claudio ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Biofilm; Candida albicans; Coxsackievirus B5 (CVB5); Human Herpesvirus type 1 (HSV 1)

Indexed keywords

HYPOCHLORITE SODIUM; NEUTRALIZING ANTIBODY;

ARTICLE; BIOFILM; CANDIDA ALBICANS; CONTROLLED STUDY; COXSACKIE VIRUS B; COXSACKIE VIRUS B5; FUNGAL STRAIN; HERPES SIMPLEX VIRUS 1; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; VIRUS INACTIVATION; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS PATHOGENESIS; VIRUS RELEASE; VIRUS STRAIN; XTT ASSAY;

CANDIDA; CANDIDA ALBICANS; COXSACKIEVIRUS; HUMAN HERPESVIRUS 1;

BIOFILM; CANDIDA ALBICANS; COXSACKIEVIRUS B5 (CVB5); HUMAN HERPESVIRUS TYPE-1 (HSV-1);

BIOFILMS; CANDIDA ALBICANS; CELL LINE; ENTEROVIRUS B, HUMAN; HERPESVIRUS 1, HUMAN; HUMANS; VIRULENCE; VIRUS DISEASES; VIRUS RELEASE;

EID: 84892805129     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2013.10.018     Document Type: Article

References (53)

1. Al-Fattani M.A., Douglas J.L. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J. Med. Microbiol. 2006, 55:999-1000.
2. Blankenship J.R., Mitchell A.P. How to build a biofilm: a fungal perspective. Curr. Opin. Microbiol. 2006, 9(6):588-594.
3. Cauda R. Candidaemia in patients with an inserted medical device. Drugs 2009, 69:33-38.
4. Cermelli C., et al. Selenite inhibition of Coxsackievirus B5 replication: implications on the etiology of Keshan disease. J. Trace Elem. Med. Biol. 2002, 16(1):41-46.
5. Cermelli C., et al. Gene expression profiling of monocytes displaying Herpes Simplex Virus type 1 induced dysregulation of antifungal defences. J. Med. Microbiol. 2009, 58:1283-1290.
6. Chandra J., et al. Biofilm formation by the fungal pathogen Candida albicans development, architecture, and drug resistance. J. Bacteriol. 2001, 183:5385-5394.
7. Chandra J., et al. In vitro growth and analysis of Candida biofilm. Nat. Protoc. 2008, 3:1909-1924.
8. Cirasola D., Sciota R., Vizzini L., Ricucci V., Morace G., Borghi E. Experimental biofilm-related Candida infections. Future Microbiol. 2013, 8:799-805.
9. Costerton J.W., et al. Bacterial biofilm in nature and disease. Annu. Rev. Microbiol. 1987, 41:435-464.
10. Donlan R.M. Biofilms and device-associated infections. Emerg. Infect. Dis. 2001, 7:277-281.
11. Donlan R.M. Biofilms: microbial life on surfaces. Emerg. Infect. Dis. 2002, 8(2):881-890.
12. Donlan R.M. Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol. 2009, 17(2):66-72.
13. Douglas L.J. Medical importance of biofilms in Candida infections. Rev. Iberoam Micol. 2002, 19:139-214.
14. Douglas L.J. Candida biofilms and their role in infection. Trends Microbiol. 2003, 11:30-36.
15. Duran A.E., et al. Usefulness of different groups of bacteriophages as model micro-organisms for evaluating chlorination. J. Appl. Microbiol. 2003, 95:29-37.
16. Flemming H.C. Sorption sites in biofilms. Water Sci. Technol. 1995, 32(8):27-33.
17. Flemming H.C., Wingender J. The biofilm matrix. Nat. Rev. Microbiol. 2010, 8:623-633.
18. Hall-Stoodley L., Costerton J.W., Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2004, 2:95-108.
19. Hall-Stoodley L., Stoodley P., Kathju S., Hoibi N., Moser C., Costerton J.W., Moter A., Bjarnsholt T. Towards diagnostic guidelines for biofilm-associated infections. FEMS Immunol. Med. Microbiol. 2012, 65(2):127-145.
20. Hanlon G.W., et al. Reduction of exopolysaccharide viscosity as an aid to bacteriophage penetration through Pseudomonas aeruginosa biofilms. Appl. Environ. Microbiol. 2001, 67:2746-3275.
21. Hughes K.A., Sutherland I.W., Jones M.V. Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiol. 1998, 144:3039-3047.
22. Jin Y., et al. Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in case of Human Immunodeficiency Virus infection. J. Clin. Microbiol. 2003, 41(7):2961-2967.
23. Jolly C., Sattentau Q.J. Retroviral spread by induction of virological synapses. Traffic 2004, 5:643-650.
24. Kojic E.M., Darouiche R.O. Candida infections of medical devices. Clin. Microbiol. Rev. 2004, 17:255-267.
25. Kuhn D.M., et al. Uses and limitations of the XTT assay in studies of Candida growth and metabolism. J. Clin. Microbiol. 2003, 41:506-508.
26. Kumamoto C.A., Vinces M.D. Alternative Candida albicans lifestyles: growth on surfaces. Ann. Rev. Microbiol. 2005, 59:113-133.
27. Kurtz M.B., et al. Characterization of echinocandin-resistant mutants of Candida albicans. Infect. Immun. 1996, 64:3244-3251.
28. Lennette E.H. General principles underlying laboratory diagnosis of virus and rickettsia infections. Diagnostic Procedures of Virus and Rickettsia Disease 1964, 45. American Public Health Association, New York. E.H. Lennette, N.H. Schmidt (Eds.).
29. Leclerc H., et al. Microbial agents associated with waterborne diseases. Crit. Rev. Microbiol. 2002, 28:371-409.
30. Li X., et al. Quantitative variation of biofilms among strains in natural populations of Candida albicans. Microbiology 2003, 149:353-362.
31. Lindenbach B.D., et al. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:3805-3809.
32. Lynch A.S., Robertson G.T. Bacterial and fungal biofilm infections. Ann. Rev. Med. 2006, 59:415-428.
33. Menaia J., et al. Monitoring the active sessile-colonisation of two drinking water distribution systems based on the protein contents in native biofilm samples. Water Sci. Technol. 2003, 47(5):169-173.
34. Mermel L.A., et al. Guidelines for the management of intravascular catheter-related infections. Clin. Infect. Dis. 2001, 32:1249-1272.
35. Munch J., et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 2007, 131:1059-1071.
36. Nejmeddine M., et al. Human T-lymphotropic virus type 1 Tax protein triggers microtubule reorientation in the virological synapse. J. Biol. Chem. 2005, 280:29653-29660.
37. Nett J., Andes D. Candida albicans biofilm development, modeling a host pathogen interaction. Curr. Opin. Microbiol. 2006, 9:1-6.
38. Pais-Correia A.M., et al. Biofilm like extracellular viral assemblies mediate HTLV cell to cell transmission at virological synapses. Nat. Med. 2010, 16:83-89.
39. Peeters E., et al. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J. Microbiol. Methods 2008, 72(2):157-165.
40. Pfaller M.A., Diekema D.J. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 2007, 20(1):133.
41. Pierce C.G., et al. A simple and reproducible 96 well-plate based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat. Protoc. 2008, 3(9):1494-1500.
42. Quignon F., et al. Poliovirus-1 inactivation and interaction with biofilm: a pilot-scale study. Appl. Environ. Microbiol. 1997, 63:978-982.
43. Ramage G., et al. Candida biofilms: an update. Eukaryot Cell. 2005, 4:633-638.
44. Skraber S., et al. Pathogenic viruses in drinking water biofilms: a public health risk?. Biofilms 2005, 2(2):105-117.
45. Stepanovic S., et al. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J. Microbiol. Methods 2000, 40(2):175-179.
46. Storey M.V., Ashbolt N.J. Persistence of two model enteric viruses (B40-8 and MS-2 bacteriophages) in water distribution pipe biofilms. Water Sci. Technol. 2001, 43(12):133-138.
47. Storey M.V., Ashbolt N.J. Entericvirions and microbial biofilms- a secondary source of public health concern?. Water Sci. Technol. 2003, 48(3):97-104.
48. Sutherland I.W., et al. The interaction of phage and biofilms. FEMS Microbiol. Lett. 2004, 232:1-6.
49. Thoulouz M.I., Alcover A. Can viruses form biofilm?. Trends Microbiol. 2011, 19(6):257-262.
50. Wimpenny J. Heterogeneity in biofilms. FEMS Microbiol. Rev. 2000, 24:661-671.
51. Wingender J. Hygienically relevant microorganisms in biofilms of man-made water systems. Biofilm Perspectives 2011, Springer International, Heidelberg, New York, (Chapter 9). H.-C. Flemming, J. Wingender, U. Szewzyk (Eds.).
52. Wingender J., Flemming H.C. Biofilms in drinking water and their role as reservoir for pathogens. Int. J. Hyg. Environ. Health 2011, 214(6):417-423.
53. Zhu M., et al. Extracellular polysaccharides do not inhibit the reaction between Streptococcus mutans and its specific immunoglobulin G (IgG) or penetration of the IgG through S. mutans biofilm. Oral Microbiol. Immunol. 2001, 16(1):54-56.